HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical modelsHang Ke, Qi‐Xiang Li(Nanjing Drum Tower Hospital)Scientific ReportsApril 3, 202310.1038/s41598-023-32547-yCited by 22SaveCiteExport RISWatch citationsRelated PapersA living biobank of matched pairs of patient-derived xenografts and organoids for cancer pharmacology|PLoS ONE|2023|23